Prestige Biopharma Group has taken its first step toward becoming a global innovation hub in the biopharma industry with the opening ceremony of its R&D control tower, the Innovation Drug Center (IDC).

With its cutting-edge research platform and global network, IDC is dedicated to the development of antibody therapeutics and biosimilars for the treatment of intractable diseases, embodying the vision of "Innovation for Life."

The international symposium held alongside the opening ceremony provided an opportunity to share achievements in biopharmaceutical technologies and platform development, while exploring the possibilities of collaboration and innovation.

Moving forward, IDC aims to lead the global biopharma industry and establish itself as a world-class biopharma cluster.

We kindly ask for your continued interest and support in the journey of the Innovation Drug Center.